Company Overview and News

Australia's Northern Territory Lifts Fracking Ban

2018-04-17 rigzone
SYDNEY, April 17 (Reuters) - Australia's Northern Territory on Tuesday lifted a nearly two-year moratorium on fracking to extract gas, unlocking vast onshore reserves in the resource-rich region and raising the possibility of other provinces following suit.
Upvote Downvote

Armour Energy generates cash flow as Kincora Gas Plant production recommences

Armour Energy Ltd (ASX:AJQ) has recommenced the processing of raw gas from existing wells at its Kincora Gas Plant located in the Surat Basin.
Upvote Downvote

Nigeria's Oranto Petroleum Signs Uganda Oil Exploration Deal

2017-10-10 rigzone
CAPE TOWN, Oct 10 (Reuters) - Nigeria's Oranto Petroleum has signed two production sharing agreements with Uganda to explore for oil and gas around Lake Albert, the company said on Tuesday.
Upvote Downvote

Armour Energy shares rise after first gas sales from Kincora Project

Armour Energy Ltd (ASX:AJQ) has commenced the commercial sales of gas from its Kincora Project located on the Roma shelf in the Bowen-Surat Basin, Queensland.
Upvote Downvote

[Opinion] Your Weekly Update: 11 - 15 Sep

2017-09-27 oilvoice
Last week in World Oil: Prices Oil prices remain close to multi-month highs as the market assesses the impact of two recent major hurricanes, as well as indications that OPEC is considering extending the current supply freeze deal beyond March 2018. Brent is trading at about US$55/b, while WTI stands at about US$50/b. Upstream Uganda has signed the first exploration deal from its 2015 licensing round.
Upvote Downvote

Uganda Signs Oil Exploration Deal With Australia's Armour Energy

2017-09-14 rigzone
KAMPALA, Sept 14 (Reuters) - Uganda signed an oil exploration deal with Australia's Armour Energy Limited on Thursday, the first under a protracted competitive licensing round launched in 2015.
Upvote Downvote

Myer boss cops $150,000 pay cut

THE Australian market looks set to open slightly higher, despite negative sentiment prevailing virtually across the board of major international bourses. At 0700 AEST on Friday, the share price futures index was up seven points, or 0.12 per cent, at 5,742.
Upvote Downvote

Uganda To Finalize Oil Exploration Deal With Nigerian Firm

2017-06-14 rigzone
KAMPALA, June 14 (Reuters) - Uganda is set to sign on Thursday two oil production sharing agreements with a Nigerian firm, enabling the company to begin exploration work, the government said on Wednesday.
Upvote Downvote

Uganda Selects Firms for Refinery Talks

2017-05-18 rigzone
KAMPALA, May 17 (Reuters) - Uganda's energy ministry said on Wednesday it would award three exploration licences next month and also said it had selected two firms with whom it would start negotiations for a possible agreement to develop a planned crude refinery. Last August Uganda selected Nigerian firms WalterSmithPetroman Oil Limited, Oranto Petroleum International, Niger Delta Petroleum Resources and Australia's Armour Energy Limited as winners for its latest licensing round.
Upvote Downvote

Armour Energy wins contract to supply gas from Kincora Project

Australia Pacific LNG is a strong counterparty gas buyer, being a joint venture between three leading oil and gas companies (Origin Energy, ConocoPhillips, and Sinopec). The first gas production and commencement of gas sales from the Kincora Project, situated on the Roma Shelf in Queensland, is targeted to be achieved by June 2017. Armour’s Phase 1 at Kincora will be the restart of gas production, commissioning and then increasing production rate to 9 terajoules per day.
Upvote Downvote

Armour Energy Agrees Investment Terms

2016-11-21 rigzone
Armour Energy Limited has agreed terms with M.H. Carnegie & Co Pty Ltd for a staged investment of up to $17.5 million worth of convertible notes, which will be used to fund the re‐start of gas production from Armour’s Kincora oil and gas Project on the Roma Shelf in Queensland.
Upvote Downvote

Armour Energy Ltd raising funds to restart gas production

This is part of a $40 million capital raising program that will also include an entitlement offer of ordinary shares to existing Armour shareholders. The company will use the funds to restart gas production from its Kincora oil and gas project on the Roma Shelf in Queensland and to refinance existing debt, creditors and working capital. Armour’s largest shareholder DGR Global Ltd is strongly supporting the capital raising initiatives with commitments to subscribe for up to $10.
Upvote Downvote

Armour Energy Ltd appoint Roger Cressey to interim CEO after first oil shipment

Armour Energy Ltd (ASX:AJQ) have appointed chief operating officer Roger Cressey to act as chief executive officer for the company on an interim basis.
Upvote Downvote

Armour Energy Ltd appoint Roger Cressey to interim CEO after first oil shipment

Armour Energy Ltd (ASX:AJQ) have appointed chief operating officer Roger Cressey to act as chief executive officer for the company on an interim basis.
Upvote Downvote

Armour Energy Ltd completes first shipment of oil from Emu Apple

Armour Energy Ltd (ASX:AJQ) has shipped the first load of crude oil produced from the Emu Apple oil field near Roma in southwest Queensland.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...